During the past decade, Neurology Associates of Ormond Beach conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 13 clinical trials were completed, i.e. on average, 61.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 9 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neurology Associates of Ormond Beach" #1 sponsor was "Sunovion" with 3 trials, followed by "Allergan" with 2 trials sponsored, "Eisai Inc." with 2 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored and "ACADIA Pharmaceuticals Inc." with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neurology Associates of Ormond Beach" #1 collaborator was "Acorda Therapeutics" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "INC Research Limited" with 1 trials as a collaborator and "Mallinckrodt ARD Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Neurology Associates of Ormond Beach" are "Multiple Sclerosis" (4 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Alzheimer Disease" (2 trials), "Episodic Migraine" (2 trials) and "Parkinson Disease" (2 trials). Many other conditions were trialed in "Neurology Associates of Ormond Beach" in a lesser frequency.

Most popular intervention types in "Neurology Associates of Ormond Beach" are "Drug" (27 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "AVP-786" (2 trials), "Atogepant" (2 trials), "Eslicarbazepine acetate" (2 trials) and "AVP-923-20" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurology Associates of Ormond Beach" are 28 trials for "All" genders.

Currently, there are NaN active trials in "Neurology Associates of Ormond Beach". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Neurology Associates of Ormond Beach, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Neurology Associates of Ormond Beach, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".